| A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial U Gillespie, A Alassaad, D Henrohn, H Garmo, M Hammarlund-Udenaes, ... Archives of internal medicine 169 (9), 894-900, 2009 | 805 | 2009 |
| On the rate and extent of drug delivery to the brain M Hammarlund-Udenaes, M Fridén, S Syvänen, A Gupta Pharmaceutical research 25, 1737-1750, 2008 | 564 | 2008 |
| AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives CS Chaurasia, M Müller, ED Bashaw, E Benfeldt, J Bolinder, R Bullock, ... Pharmaceutical research 24, 1014-1025, 2007 | 439 | 2007 |
| Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport S Syvänen, Ö Lindhe, M Palner, BR Kornum, O Rahman, B Långström, ... Drug metabolism and disposition 37 (3), 635-643, 2009 | 407 | 2009 |
| Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease M Agrawal, DK Tripathi, S Saraf, S Saraf, SG Antimisiaris, S Mourtas, ... Journal of controlled release 260, 61-77, 2017 | 340 | 2017 |
| Structure− brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids M Fridén, S Winiwarter, G Jerndal, O Bengtsson, H Wan, U Bredberg, ... Journal of medicinal chemistry 52 (20), 6233-6243, 2009 | 251 | 2009 |
| The role of P‐glycoprotein in blood‐brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (−/−) and mdr1a (+/+) mice R Xie, M Hammarlund‐Udenaes, AG De Boer, ECM De Lange British journal of pharmacology 128 (3), 563-568, 1999 | 248 | 1999 |
| In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics E Boström, USH Simonsson, M Hammarlund-Udenaes Drug metabolism and disposition 34 (9), 1624-1631, 2006 | 238 | 2006 |
| In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids M Friden, A Gupta, M Antonsson, U Bredberg, M Hammarlund-Udenaes Drug metabolism and disposition 35 (9), 1711-1719, 2007 | 215 | 2007 |
| Drug equilibration across the blood—brain barrier-pharmacokinetic considerations based on the microdialysis method M Hammarlund-Udenaes, LK Paalzow, ECM de Lange Pharmaceutical research 14, 128-134, 1997 | 210 | 1997 |
| Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone T Okura, A Hattori, Y Takano, T Sato, M Hammarlund-Udenaes, ... Drug metabolism and disposition 36 (10), 2005-2013, 2008 | 198 | 2008 |
| Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype C von Bahr, G Movin, C Nordin, A Lidén, M Hammarlund‐Udenaes, ... Clinical Pharmacology & Therapeutics 49 (3), 234-240, 1991 | 194 | 1991 |
| Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods M Fridén, F Bergström, H Wan, M Rehngren, G Ahlin, ... Drug Metabolism and Disposition 39 (3), 353-362, 2011 | 189 | 2011 |
| Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments'(MAI, STOPP and STARTs') ability to predict hospitalization–analyses … U Gillespie, A Alassaad, M Hammarlund-Udenaes, C Mörlin, D Henrohn, ... PloS one 8 (5), e62401, 2013 | 168 | 2013 |
| Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine E Bostrom, M Hammarlund-Udenaes, USH Simonsson ANESTHESIOLOGY-PHILADELPHIA THEN HAGERSTOWN- 108 (3), 495, 2008 | 168 | 2008 |
| Brain distribution of cetirizine enantiomers: Comparison of three different tissue-to-plasma partition coefficients: Kp, Kp, u, and Kp, uu A Gupta, P Chatelain, R Massingham, EN Jonsson, ... Drug metabolism and disposition 34 (2), 318-323, 2006 | 166 | 2006 |
| The use of microdialysis in CNS drug delivery studies: pharmacokinetic perspectives and results with analgesics and antiepileptics M Hammarlund-Udenaes Advanced drug delivery reviews 45 (2-3), 283-294, 2000 | 166 | 2000 |
| Development of a high-throughput brain slice method for studying drug distribution in the central nervous system M Friden, F Ducrozet, B Middleton, M Antonsson, U Bredberg, ... Drug metabolism and disposition 37 (6), 1226-1233, 2009 | 157 | 2009 |
| Methodological aspects of the use of a calibrator in in vivo microdialysis–further development of the retrodialysis method MR Bouw, M Hammarlund-Udenaes Pharmaceutical research 15, 1673-1679, 1998 | 155 | 1998 |
| Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats—a microdialysis study MR Bouw, M Gårdmark, M Hammarlund-Udenaes Pharmaceutical research 17, 1220-1227, 2000 | 137 | 2000 |
